Shimizu J, Sakamoto A, Ogawa R
Department of Anesthesiology, Nippon Medical School, Tokyo, Japan.
J Nippon Med Sch. 2001 Jun;68(3):238-45. doi: 10.1272/jnms.68.238.
The adenosine triphosphate-dependent potassium (K(ATP)) channel has been proposed to play an important role in the cardioprotective effect of isoflurane (ISO). However, the question of whether the K(ATP) channel, sarcolemmal or mitochondrial is the main contributor to the effect has not been clarified. The major aim of the present study was to determine whether or not the mitochondrial potassium channel was a site of action for ISO. Whether there was an acute "memory phase", in which drugs were not detected in the tissues, but the protective effect still remained in the ischemic preconditioning (IP) -like effect of ISO was also investigated. Dangling participle isolated rat hearts, a 20-min normothermic nonperfused phase was maintained to produce a global ischemia. Under these ischemic conditions, the effects of ISO, sodium 5-hydroxydecanoate (5HD: a selective mitochondrial K(ATP) channel antagonist), and ISO combined with 5HD on cardiac performance were examined. To all these four groups, (non-treated group, ISO group, 5HD group and ISO plus 5HD group, n=6 each) drugs were given for 30 min. After 10 min of drug-free perfusion (pre-ischemia restabilization period), 20 min of ischemia followed. Then the cardiac performance and the creatine kinase (CK) release during the reperfusion period were tested. In the non treated group and 5HD group, cardiac performance was stable during the treated period and pre-ischemia the restabilization period. In the ISO group and ISO plus 5HD group, heart rate (HR), left ventricular (LV) systolic pressure, and LV maximum rate of development of tension (dP/dtMax) during the drug-treated period became gradually and linearly worse. However, these values were the same as in the non-treated group and 5HD group at the end of the pre-ischemia restabilization period. So 5HD itself had no hemodynamic effect; nor did it have any influence on the actions of ISO. At the end of the pre-ischemia restabilization period, the significant hemodynamic differences among the groups diminished and ISO was not detected in the solution. In the post-reperfusion period, except for the ISO group, (non treated group, 5HD group and ISO plus 5HD group) cardiac performances were drastically decreased. ISO significantly ameliorated the dysfunction of cardiac output, LV systolic pressure and LV+dP/dtMax. The CK level in the coronary effluent during reperfusion was also significantly reduced by ISO. 5HD completely inhibited these cardiac effects of ISO. Activation of the adenosine triphosphate sensitive mitochondrial potassium channel is involved in the cardioprotective effect of ISO, and the action of this agent has an acute"memory phase" like ischemic preconditioning.
三磷酸腺苷依赖性钾(K(ATP))通道被认为在异氟烷(ISO)的心脏保护作用中发挥重要作用。然而,K(ATP)通道,即肌膜或线粒体的K(ATP)通道是否是产生该效应的主要因素这一问题尚未明确。本研究的主要目的是确定线粒体钾通道是否为ISO的作用位点。同时还研究了是否存在一个急性“记忆期”,即在组织中未检测到药物,但ISO的缺血预处理(IP)样效应仍存在。采用离体大鼠心脏,维持20分钟常温非灌注期以产生全心缺血。在这些缺血条件下,检测ISO、5-羟基癸酸钠(5HD:一种选择性线粒体K(ATP)通道拮抗剂)以及ISO与5HD联合应用对心脏功能的影响。对所有四组(未处理组、ISO组、5HD组和ISO加5HD组,每组n = 6)给药30分钟。在无药灌注10分钟(缺血前再稳定期)后,接着进行20分钟缺血。然后检测再灌注期的心脏功能和肌酸激酶(CK)释放。在未处理组和5HD组中,处理期和缺血前再稳定期心脏功能稳定。在ISO组和ISO加5HD组中,药物处理期的心率(HR)、左心室(LV)收缩压和LV最大张力发展速率(dP/dtMax)逐渐且呈线性恶化。然而,在缺血前再稳定期末,这些值与未处理组和5HD组相同。所以5HD本身无血流动力学效应;对ISO的作用也无任何影响。在缺血前再稳定期末,各组间显著的血流动力学差异减小,且溶液中未检测到ISO。在再灌注期,除ISO组外,(未处理组、5HD组和ISO加5HD组)心脏功能急剧下降。ISO显著改善了心输出量、LV收缩压和LV + dP/dtMax的功能障碍。ISO还显著降低了再灌注期冠脉流出液中的CK水平。5HD完全抑制了ISO的这些心脏效应。三磷酸腺苷敏感性线粒体钾通道的激活参与了ISO的心脏保护作用,且该药物的作用具有类似缺血预处理的急性“记忆期”。